Sea snail compound reduces cancer risk

Sea snail compound reduces cancer risk
The anti-cancer therapeutic effect of Dicathais orbita hypobranchial gland extract shows promise in resisting colorectal cancer cells. Credit: Flinders University

The remarkable ability of a small Australian sea snail to produce a colourful purple compound to protect its eggs is proving even more remarkable for its potential in a new anti-cancer pharmaceutical.

Researchers at Flinders University, Southern Cross University and Monash University in Australia have isolated one compound in the gland secretions from the Australian white rock sea snail (Dicathasis orbita) which has not only antibacterial and anti-inflammatory qualities, but important anti- properties.

"After a decade of work, we have found an active compound derived from the substance produced by the mollusc's gland which could be used as a preventative in ," says senior lead scientist Professor Catherine Abbott from Flinders University. "We're very excited about these latest results and hope to attract investment from a pharma company to work on a new drug to reduce development of colorectal cancer tumours."

Using the latest mass spectrometry technology, the research team has been able to pinpoint the lead active compound which, in future, could be put to good work.

Colorectal cancer is the second leading cause of the 9.6 million cancer deaths every year, with the World Health Organization reporting 862,000 deaths in 2018.

Natural from marine and terrestrial plants and animals are valuable sources of current and future medicines for human health, says Southern Cross University marine scientist Professor Kirsten Benkendorff, who is also researching the potential of replicating the snail species' anti-inflammatory compound.

"In this latest research we have not only show that a specific snail compound can prevent the formation of tumours in a colon cancer model, but we were also able to use sophisticated technology to trace the metabolism of the compound inside the body," says Professor Benkendorff. "This is very important for because it helps demonstrate the absence of potentially toxic side-effects".

Along with tracking the active compound inside the body to confirm it reaches the colon where is has the anti-tumor effect—which is important for oral drug delivery—the snail compound comes from a class of compounds called "indoles" which are commonly found in both natural plant medicines and some pharmaceuticals.

"We were able to use the fact that snail compound contains bromine like a unique fingerprint to trace how these types of compounds are metabolised inside the body and identify some potentially toxic metabolites from the crude extracts that were not found with the pure snail compound," Professor Benkendorff adds.

"This research is very important for understanding the safety of these types of natural compounds for human medicine."


Explore further

Researchers make potential breakthrough in cancer drug development

More information: David Andre Rudd et al, Mapping insoluble indole metabolites in the gastrointestinal environment of a murine colorectal cancer model using desorption/ionisation on porous silicon imaging, Scientific Reports (2019). DOI: 10.1038/s41598-019-48533-2
Journal information: Scientific Reports

Citation: Sea snail compound reduces cancer risk (2019, August 26) retrieved 17 October 2019 from https://phys.org/news/2019-08-sea-snail-compound-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
171 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more